US 11623002
ALK polypeptides and methods of use thereof
granted A61KA61K2039/55555A61K2039/6018
Quick answer
US patent 11623002 (ALK polypeptides and methods of use thereof) held by Elicio Therapeutics, Inc. expires Mon Apr 06 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Elicio Therapeutics, Inc.
- Grant date
- Tue Apr 11 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 06 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 5
- CPC classes
- A61K, A61K2039/55555, A61K2039/6018, A61K2039/6031, A61K2039/627